European Companies Search Engine
U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system Sec 26 Apr 2022 U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system, United States
Text
Entity
| entityName | Novartis AG |
| Cik | 1114448 |
| Form | 20-F/A |
| Filed | 2022-04-26 |
| Fp | FY |
| Fy | 2021 |
| Accn | 0001104659-22-050394 |
Facts up to 2021-12-31
| Description | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. |
| Fact | EntityCommonStockSharesOutstanding |
| Frame | CY2021Q4I |
| Label | Entity Common Stock, Shares Outstanding |
| Taxonomy | dei |
| Unit | shares |
| Val | 2,234,939,948 |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Novartis AG, Basle, Switzerland.